Have a personal or library account? Click to login

Use of extended half-life factor IX products in the surgical setting: case series from a UK haemophilia centre

Open Access
|Sep 2025

Figures & Tables

Figure 1.

Product comparison data for three patients who received a SHL-FIX product for a prior surgery
Product comparison data for three patients who received a SHL-FIX product for a prior surgery

Patient and surgery details

PATIENTAGE AT MOST RECENT SURGERY (YEARS)HEMOPHILIA SEVERITYWEIGHT (KG)TYPE OF PROCEDURESURGERY CATEGORYSITE (LOCATION)LENGTH OF INPATIENT STAY (DAYS)FIX PRODUCT USEDFIX IU/KG/DOSENUMBER OF FIX DOSESTOTAL FIX CONSUMPTION (IU)OUTCOME
142Severe87.8Dental abscessMinorIP (RFH)6rIX-FP27.3512,000No bleeding
Arthroscopic cheilectomyMajorIP (RFH)339.927,000No bleeding
Right ankle manipulationMajorIP (RFH)256.915,000No bleeding
Right ankle fusionMajorIP (RFH)441.8311,000No bleeding
255Mild (baseline FIX 6–9 IU/dL)94.4Prostate biopsyMinorOP (remote)0N9-GP28.238,000No bleeding
Spinal cord implantMajorIP (other)135.3310,000No bleeding
Left shoulder steroid injectionMinorOP (remote)028.228,000No bleeding
3*35Severe77Left ankle radiosynovectomyMinorOP (RFH)0rFIXFc26.026,000No bleeding
4*76Severe58.8Hip revisionMajorIP (RFH)16rIX-FP35.11531,000No bleeding
63.7Prostate biopsyMinorIP (RFH)247.126,000No bleeding
539Moderate (baseline FIX 4 IU/dL)85Right inguinal hernia repairMajorIP (remote)1rIX-FP51.0313,000No bleeding
658Moderate (baseline FIX 3 IU/dL)89Dental procedureMinorOP (remote)0rIX-FP67.416,000No bleeding
Dental procedureMinorOP (remote)067.416,000No bleeding
Dental procedureMinorOP (remote)067.416,000No bleeding
743Severe95Left total hip replacementMajorIP (RFH)6rFIXFc60.5846,000No bleeding
816Severe55Testicular torsion repairMinorIP (RFH)3rFIXFc47.3513,000No bleeding
954Severe83Left knee radiosynovectomyMinorOP (RFH)0rIX-FP36.113,000No bleeding
84Left knee radiosynovectomyMinorOP (RFH)047.628,000No bleeding
1063Severe85.6Ankle fixationMajorIP (RFH)3N9-GP40.927,000No bleeding
Steroid injectionMinorOP (remote)035.013,000No bleeding
Spinal decompressionMajorIP (remote)152.629,000No bleeding
Right elbow radiosynovectomyMinorOP (RFH)035.013,000No bleeding

Patient demographics

PATIENT AGE AT TIME OF SURGERY, YEARS
Mean ± SD48.1 ± 16.7
Median (range)48.5 (16–76)
ETHNICITY, N (%)
White10 (100%)
Asian0
Black0
SURGERY TYPE, N (%)
N = 22
Major9 (40.9%)
Minor13 (59.1%)

Product comparison data for three patients who received a SHL FIX product for a prior surgery

PATIENTAGE AT INDEX SURGERY (YEARS)HEMOPHILIA SEVERITYWEIGHT (KG)TYPE OF SURGERYSURGERY CATEGORYSITE (LOCATION)LENGTH OF INPATIENT STAY (DAYS)DURATION OF CONTINUOUS INFUSIONFIX PRODUCT USEDNUMBER OF DOSES OF FIX PRODUCTTOTAL FIX CONSUMPTION (IU)OUTCOME
476Severe58.8Hip revisionMajorIP (RFH)160rIX-FP1531,000No bleeding
6963.79Total hip replacementMajorIP (RFH)225 daysSHL FIX30161,600No bleeding
1154Mild96.0Prostate biopsyMinorOP (remote)00rIX-FP311,000No bleeding
5494.4Prostate biopsyMinorOP (RFH)30SHL FIX526,000
1254Severe85.6Ankle synovectomyMinorOP (RFH)00rIX-FP27,500
5484.5Ankle synovectomyMinorOP (RFH)00SHL FIX314,00

Considerations for clinical nurse specialists when planning surgery

PRE-SURGERYPOST-SURGERY
  • Diagnosis

  • Clinical phenotype/bleed history

  • The severity of factor levels

  • Pharmacokinetic study

  • Inhibitor status

  • Surgery type (major/minor), bleed risk, anaesthesia

  • Ability to self-infuse

  • Timing of the surgery: 2nd on the list in the morning/1st in the afternoon, beginning/end of the week

  • Which hospital/location: availability of the haematology team

  • Lab onsite: is it equipped to manage levels as required?

  • Inpatient/day case

  • Patient venous access

  • Type of FIX: EHL/SHL

  • Frequency of treatment

  • Length of treatment

  • Distance to hospital

  • Ability to self-infuse

Statistical analysis of variables associated with total FIX consumption

VARIABLEMEAN FIX CONSUMPTION IUMEDIAN FIX CONSUMPTION IU (RANGE, N)P-VALUE*
Inpatient procedure locationat RFH10,66610,000 (9,000–13,000, n=3)n.s.
at other sites15,22211,000 (5,000–46,000, n=9)
Outpatient procedure locationat RFH5,0004,500 (3,000–8,000, n=4)n.s.
at other sites6,2006,000 (3,000, 8,000; n=5)
SurgeryMajor15,444.410,000 (5,000–46,000; n=9)p < .05
Minor6,7506,000 (3,000–12,000; n=12)
ProcedureInpatient14,083.310,500 (5,000–41,000; n=12p < .05
Outpatient5,666.66,000 (range 3,000–8,000; n=9
Language: English
Page range: 96 - 103
Published on: Sep 16, 2025
Published by: Haemnet Ltd
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year

© 2025 Molly Ndebele, Emma Charnick, Nawal Asir, Elsa Aradom, published by Haemnet Ltd
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.